ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,294.10
-0.42%
S&P ASX All Technology
3,845.90
-0.28%
Brent Oil
79.285
0.00%
US Dollar vs AUD
1.6276
0.00%
Bitcoin
94,151.87
-0.59%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Pluxee NV (PLX) Share Price

Pluxee NV

Pluxee NV (PLX)

Protalix BioTherapeutics Inc
Pyrolyx AG
Point Loma Resources Ltd
22.09
0.25
(1.14%)
Closed 11 January 3:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
22.09
Bid
21.95
Offer
22.30
Volume
154,522
21.575 Day's Range 22.29
15.214 52 Week Range 31.82
Market Cap
3.251B
Previous Close
21.84
Open
21.87
Last Trade
68
@
22.09
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
157,937
Shares Outstanding
147,174,692
Dividend Yield
3.17%
PE Ratio
24.44
Earnings Per Share (EPS)
0.9
Revenue
1.21B
Net Profit
133M

About Pluxee NV

Sector
Employment Agencies
Industry
Employment Agencies
Website
www.pluxeegroup.com
Headquarters
Issy-les-moulineaux, Hauts-de-seine, Fra
Founded
-
Pluxee NV is listed in the Employment Agencies sector of the Euronext with ticker PLX. The last closing price for Pluxee NV was 21.84 €. Over the last year, Pluxee NV shares have traded in a share price range of 15.214 € to 31.82 €.

Pluxee NV currently has 147,174,692 shares in issue. The market capitalisation of Pluxee NV is 3.21 € billion. Pluxee NV has a price to earnings ratio (PE ratio) of 24.44.

Ask ADVFN Intelligence (AI)

PLX Latest News

More News

Half-year report on the liquidity contract as of December 31, 2024

Half-year report on the liquidity contract as of December 31, 2024 Half-year report on the liquidity contract as of December 31, 2024Issy-les-Moulineaux, France – January 9, 2025 Regulated...

09 January 2025
UK Regulatory

Bilan semestriel du contrat de liquidité au 31 décembre 2024

Bilan semestriel du contrat de liquidité au 31 décembre 2024 Bilan semestriel du contrat de liquidité au 31 décembre 2024Issy-les-Moulineaux, France – 9 janvier 2025 Information réglementée Bilan...

09 January 2025
UK Regulatory

Chiffre d’affaires du 1er trimestre de l’exercice fiscal 2025

Chiffre d’affaires du 1er trimestre de l’exercice fiscal 2025 Chiffre d’affaires du 1er trimestre de l’exercice fiscal 2025  Un début d’année solide, en ligne avec les objectifs stratégiques...

08 January 2025
UK Regulatory

Fiscal Q1 2025 Revenues

Fiscal Q1 2025 Revenues Fiscal Q1 2025 Revenues Issy-les-Moulineaux, France – January 8th, 2025 A robust start to the year, in line with the Group's strategic and financial objectives Highlights...

08 January 2025
UK Regulatory

Résultats de l’Assemblée générale annuelle d’actionnaires pour l’exercice 2024

Résultats de l’Assemblée générale annuelle d’actionnaires pour l’exercice 2024 Résultats de l’Assemblée générale annuelle d’actionnaires pour l’exercice 2024 Amsterdam-Schiphol : 18 décembre...

19 December 2024
UK Regulatory

Voting results of the Fiscal 2024 Annual General Meeting of Pluxee

Voting results of the Fiscal 2024 Annual General Meeting of Pluxee Voting results of the Fiscal 2024 Annual General Meeting of Pluxee Amsterdam-Schiphol, December 18, 2024 //  Pluxee N.V...

19 December 2024
UK Regulatory

Pluxee acquires Beneficio Facil in Brazil and reinforces its employee mobility offer

Pluxee acquires Beneficio Facil in Brazil and reinforces its employee mobility offer Pluxee acquires Benefício Fácil in Brazil and reinforces its employee mobility offer  Pluxee to reinforce its...

29 November 2024
UK Regulatory

Pluxee renforce son offre mobilité pour les salariés au Brésil avec l’acquisition de Benefício Fácil

Pluxee renforce son offre mobilité pour les salariés au Brésil avec l’acquisition de Benefício Fácil Pluxee renforce son offre mobilité pour les salariés au Brésil avec l’acquisition de Benefício...

29 November 2024
UK Regulatory

Pluxee convenes its Fiscal 2024 Annual General Meeting of shareholders

Pluxee convenes its Fiscal 2024 Annual General Meeting of shareholders Pluxee convenes its Fiscal 2024 Annual General Meeting of shareholders Paris: November 6, 2024 // Today, Pluxee announced the...

06 November 2024
UK Regulatory

Pluxee convoque son Assemblée générale annuelle d’actionnaires pour l’exercice 2024

Pluxee convoque son Assemblée générale annuelle d’actionnaires pour l’exercice 2024 Pluxee convoque son Assemblée générale annuelle d’actionnaires pour l’exercice 2024 Paris : 6 novembre 2024 //...

06 November 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.5118.891280947318.5822.2918.2316518120.62451215DE
42.24211.295848448219.84822.2917.9611758419.49425907DE
124.74227.33456306217.34822.2915.21415793718.9715795DE
26-1.545-6.5369155912823.63523.8415.21414761119.68877844DE
52-6.41-22.491228070228.531.8215.21426110425.31003244DE
156-6.41-22.491228070228.531.8215.21426110425.31003244DE
260-6.41-22.491228070228.531.8215.21426110425.31003244DE

PLX - Frequently Asked Questions (FAQ)

What is the current Pluxee NV share price?
The current share price of Pluxee NV is 22.09 €
How many Pluxee NV shares are in issue?
Pluxee NV has 147,174,692 shares in issue
What is the market cap of Pluxee NV?
The market capitalisation of Pluxee NV is EUR 3.21B
What is the 1 year trading range for Pluxee NV share price?
Pluxee NV has traded in the range of 15.214 € to 31.82 € during the past year
What is the PE ratio of Pluxee NV?
The price to earnings ratio of Pluxee NV is 24.44
What is the cash to sales ratio of Pluxee NV?
The cash to sales ratio of Pluxee NV is 2.69
What is the reporting currency for Pluxee NV?
Pluxee NV reports financial results in EUR
What is the latest annual turnover for Pluxee NV?
The latest annual turnover of Pluxee NV is EUR 1.21B
What is the latest annual profit for Pluxee NV?
The latest annual profit of Pluxee NV is EUR 133M
What is the registered address of Pluxee NV?
The registered address for Pluxee NV is 16 RUE DU PASSEUR DE BOULOGNE, ISSY-LES-MOULINEAUX, HAUTS-DE-SEINE, 92130
What is the Pluxee NV website address?
The website address for Pluxee NV is www.pluxeegroup.com
Which industry sector does Pluxee NV operate in?
Pluxee NV operates in the EMPLOYMENT AGENCIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLCOTCoretech 5
0.012 €
(140.00%)
90.21k
ALCABCabasse SA
0.72 €
(41.18%)
16.96k
ALAGOEPango SA
0.1828 €
(21.87%)
9.37M
LEBLLcx Leblanc Chr
0.356 €
(18.67%)
4
ALALOAcheterLouerFR
0.11 €
(15.55%)
73.87k
BNBSTonner Drones
0.001 €
(-50.00%)
23.99k
DBVDBV Technologies
0.875 €
(-23.91%)
4.89M
MLCOUCourbet
1.75 €
(-15.87%)
51
MLAZRThe Azur Selection SA
1.00 €
(-15.25%)
130.18k
PROACProactis SA
0.0565 €
(-13.74%)
560
ATOAtos SE
0.002 €
(0.00%)
1.75B
BCPBanco Comercial Portugues SA
0.4802 €
(0.04%)
53.25M
ALCYBCybergun
0.0001 €
(0.00%)
20.24M
EDPEDP SA
2.974 €
(-4.77%)
15.95M
ALVERVergnet
0.0018 €
(0.00%)
15.63M

Discussion

View Full Feed
Zorax Zorax 33 seconds ago
North Korea fighting russia's war is like us going to Vietnam sort of. Soldiers themselves have no real clue why they are there.

I've noticed something else about this site. Since the beginning of the war their map always showed red dots that most of them were labeled 'military deplo
axelvento axelvento 41 seconds ago
It provides hope’: Groundbreaking vaccine being developed to target deadliest form of breast cancer

One day, it might be possible to eliminate breast cancer as a disease,” said Dr. Amit Kumar, the Chairman & CEO of Anixa Biosciences, who helped develop the vaccine.

http
ANIX
moondogaz moondogaz 2 minutes ago
agreed
WNFT
imafan imafan 2 minutes ago
Eeyore just can't sit back and be entertained, no, Eeyore must get on stage and openly reveal time and time again his obvious short position and his desperation and infatuation to want to be like Eric, all from his Mommy's basement. LOL! $50 million is just the beginning... ONWARD!!!
HHSE
SSKILLZ1 SSKILLZ1 3 minutes ago
VMI/VMIR Differential Chart
[pre]
VMI VMIR Differential
1/3/2025 0.15% 0.15% 0.00%
1/10/2025 -2.43% -2.43% 0.00%
[/pre]
dewophile dewophile 3 minutes ago
There are no notes to pay down and they could sell the remainder of the royalty for another years worth of cash on top of the 2 plus years cash they already have.
I do agree a partner sooner than later would be nice but the situation is far from desperate like you make it sound.
SSKILLZ1 SSKILLZ1 4 minutes ago
VMI/VMIR Differential Chart
[pre]
VMI VMIR Differential
1/3/2025 0.15% 0.15% 0.00%
1/10/2025 -2.43% -2.43% 0.00%
[/pre]
Hoghead7 Hoghead7 5 minutes ago
Ballard, very good news. We're coming
https://fuelcellsworks.com/2025/01/10/fuel-cells/microsoft-caterpillar-and-ballard-data-center-partnership-earns-top-doe-award
FCEL
StayHumble StayHumble 5 minutes ago
"SEC💹catches🎅🏿&👽ArtificiallyDeflating Prices 2Buy Shares"


6, 12, 2023 —

SEC charged investment adviser Sabby Management LLC & managing partner,Hal D. Mintz,w/ fraud in connection w/ a long running scheme involving misrepresentat
HMBL
SSKILLZ1 SSKILLZ1 5 minutes ago
VMI (Sorted by % Return)
[pre]
Symbol % Up/Down
ETCC 22.45%
PSIX 20.34%
VTLE 15.27%
COLL 14.87%
CXB.TO 9.93%
USMT 9.36%
REI 8.82%
NOG 7.53%
ARMN 7.14%
SBH 6.99%
AHCO 6.51%
OMI 6.27%
ARMN AVNW ETCC
SSKILLZ1 SSKILLZ1 6 minutes ago
VMI (Sorted by % Return)
[pre]
Symbol % Up/Down
ETCC 22.45%
PSIX 20.34%
VTLE 15.27%
COLL 14.87%
CXB.TO 9.93%
USMT 9.36%
REI 8.82%
NOG 7.53%
ARMN 7.14%
SBH 6.99%
AHCO 6.51%
OMI 6.27%
ARMN AVNW ETCC
dinogreeves dinogreeves 6 minutes ago
Relatively low volume today, I think the tradable float could get locked with another 60-70 million volume in one day alone, the rest will be history.
SMCI
LOB LOB 6 minutes ago
I thought so too. Maybe it will start closing strong next week.
BCDS
SSKILLZ1 SSKILLZ1 6 minutes ago
VMI (As of 1/10/25)

The VMI is Down -2.43%, after this week’s performance. So without further ado the info is below.
[pre]
Symbol % Up/Down
AATC -0.88%
ACCO -4.38%
AHCO 6.51%
AMPH -2.07%
AMRX 0.63%
ARMN 7.14%
ASIX
ARMN AVNW ETCC
CommonCents3 CommonCents3 7 minutes ago
This is the most laughable bash that continues to surface. Chris Missling is already wealthy beyond his wildest dreams. He doesn't have to do anything fraudulent or underhanded to risk his future. 

This take is beyond ridiculous, but par for the course for ur history. 

AVXL
SSKILLZ1 SSKILLZ1 7 minutes ago
VMI (As of 1/10/25)

The VMI is Down -2.43%, after this week’s performance. So without further ado the info is below.
[pre]
Symbol % Up/Down
AATC -0.88%
ACCO -4.38%
AHCO 6.51%
AMPH -2.07%
AMRX 0.63%
ARMN 7.14%
ASIX
ARMN AVNW ETCC
blackhawks blackhawks 7 minutes ago
To paraphrase Harry Truman. We don't hate here. We just present verifiable facts and he thinks it's hateful.

The title comes from an incident that took place during the 1948 presidential election campaign. In Bremerton, Washington, Truman delivered a speech attacking the Republicans.
Researchfyi Researchfyi 7 minutes ago
There’s more….

And this one is highly rated

https://smartwearablesinsider.com/ultrahuman-secures-fda-approval-for-afib-detection

And then there is this article…

Someone has it out against the Evie ring…

https://smartwearables
LQMT
axelvento axelvento 8 minutes ago
if approved, sasanlimab would be the first PD-1 inhibitor, in combination with BCG, to significantly prolong event-free survival in this patient population
BCG
yadotn yadotn 8 minutes ago
MRNJ>>Confident>>Significant Impact>>Around The World

MRNJ
OTCMarkets
Press Release
January 17, 2023
"We're confident that AI-Chat will have a significant impact on various industries and individuals around the world and can't wait to see it in action.”-Joe
MRNJ
silvr_surfr silvr_surfr 9 minutes ago
Revvity is the renamed Perkin Elmer company after they spun out part of it to focus on diagnostics. Interestingly, Ampersand Capital (Patrick Walsh) sold one of their portfolio companies to Perkin Elmer in 2021.Is this just a coincidence or part of a larger strategic plan?
ANIP
microchips microchips 11 minutes ago
As you remember, Moneyball was about getting singles and walks over home runs. And that was winning baseball. That's also exactly how I see the situation. They were going for the home run for so long and now it's going to be a bunch of singles and an occasional home run.
LWLG
abracky abracky 11 minutes ago
style="font-size: 16px" There always been a lot of talk on shorting stocks of this company to keep the share price down.
style="font-size: 16px" 
style="font-size: 16px"IMO
style="font-size: 16px"Do this to kill the shorting. 
style="font-s
CLF
SSKILLZ1 SSKILLZ1 12 minutes ago
VMIR (As Of 1/10/25)

Daily Performance
Value Microcap Index:-1.66%
Value Microcap Index Rebalanced:-1.66%

Overall Performance
Value Microcap Index: -2.43% (Worst Levels of 2025)
Value Microcap Index Rebalanced:-2.43% (Worst Levels of 2025)

Your Recent History

EU
PLX
Pluxee NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads